Incidence, risk factors, and outcomes of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: A systematic review and meta-analysis

被引:3
|
作者
Bai, Jiang [1 ]
Yin, Xinyu [2 ]
Li, Jiaqi [2 ]
Li, Jia-Qi [2 ]
Niu, Yanna [2 ]
Li, Zhenhua [2 ]
Li, Jing [2 ]
Zhou, Yun [1 ,3 ]
机构
[1] Shanxi Med Univ, Hosp 5, Shanxi Prov Peoples Hosp, Dept Nephrol, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Clin Med Coll 2, Taiyuan, Shanxi, Peoples R China
[3] Shanxi Med Univ, Hosp 5, Shanxi Prov Peoples Hosp, Dept Nephrol, Taiyuan 030001, Shanxi, Peoples R China
关键词
focal segmental glomerulosclerosis; kidney transplantation; meta-analysis; pediatrics; risk factors; RENAL-TRANSPLANTATION; DISEASE RECURRENCE; CHILDREN; POSTTRANSPLANTATION; EXPERIENCE; ALLOGRAFTS;
D O I
10.1111/ctr.15119
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundFocal segmental glomerulosclerosis is the most prevalent acquired kidney disease leading to end-stage renal disease in children and has a propensity for recurring in the transplanted kidney. The recurrence of FSGS after kidney transplantation in children varies greatly. In addition, the risk factors and outcomes of recurrence of FSGS remain controversial. This study evaluated the recurrence rate, risk factors, and prognosis of FSGS after kidney transplantation in order to provide advice and assistance in clinical decision-making for pediatric kidney transplantation.MethodsPubMed, Embase, Web of Science, CNKI, and other databases were searched from the establishment of the repository to March 2022. We extracted data on incidence, risk factors, and outcomes.ResultsThe results showed that the recurrence rate of primary FSGS in children after renal transplantation was 48% (95% CI 36%-59%) and the recurrence rate of FSGS (all forms) was 35% (95% CI 17%-52%). The graft loss rate of primary FSGS in children after kidney transplantation was 29% (95% CI 17%-42%) and the graft loss rate of FSGS (all forms) was 29% (95% CI 4%-62%). 57% (95% CI 42%-73%) of pediatric patients with recurrent primary FSGS showed complete remission. Risk factor analyses showed that age of onset (SMD .69, 95% CI .20-1.19, p = .006) was related to the recurrence of primary FSGS, whereas the living related donor was not a risk factor for recurrent primary FSGS in pediatrics after kidney transplantation (OR 1.22, 95% CI .48-3.10, p = .674).ConclusionsThe recurrence rate and graft loss rate of FSGS in children after kidney transplantation were relatively high. Age at onset was associated with a risk for recurrent primary FSGS, whereas the living related donor was not a risk factor for recurrent FSGS in pediatric kidney recipients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Incidence and risk factors for recurrent focal segmental glomerulosclerosis after kidney transplantation: a meta-analysis
    Bai, Jiang
    Zhang, Tianxiang
    Wang, Yan
    Cao, Jiajing
    Duan, Zihui
    Ji, Linghui
    Zhou, Yun
    Hao, Chuan
    Guo, Qiang
    RENAL FAILURE, 2023, 45 (01)
  • [2] Risk factors associated with allograft failure in pediatric kidney transplant recipients with focal segmental glomerulosclerosis
    Koh, Lee Jin
    Martz, Karen
    Blydt-Hansen, Tom David
    PEDIATRIC TRANSPLANTATION, 2019, 23 (05)
  • [3] Clinical features and outcomes of kidney transplant recipients with focal segmental glomerulosclerosis recurrence
    Mansur, Juliana B.
    Sandes-Freitas, Taina V.
    Kirsztajn, Gianna M.
    Cristelli, Marina P.
    Mata, Gustavo F.
    de Paula, Mayara I.
    Grenzi, Patricia C.
    Martins, Suelen B. S.
    Felipe, Claudia R.
    Tedesco-Silva, Helio
    Pestana, Jose O. M.
    NEPHROLOGY, 2019, 24 (11) : 1179 - 1188
  • [4] Pregnancy Outcomes in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
    Deshpande, N. A.
    James, N. T.
    Kucirka, L. M.
    Boyarsky, B. J.
    Garonzik-Wang, J. M.
    Montgomery, R. A.
    Segev, D. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2388 - 2404
  • [5] Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis
    Boonphiphop Boonpheng
    Panupong Hansrivijit
    Charat Thongprayoon
    Shennen A Mao
    Pradeep K Vaitla
    Tarun Bathini
    Avishek Choudhury
    Wisit Kaewput
    Michael A Mao
    Wisit Cheungpasitporn
    World Journal of Transplantation, 2021, 11 (07) : 303 - 319
  • [6] Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients
    Straatmann, Caroline
    Kallash, Mahmoud
    Killackey, Mary
    Iorember, Franca
    Aviles, Diego
    Bamgbola, Oluwatoyin
    Carson, Thomas
    Florman, Sander
    Vehaskari, Matti V.
    PEDIATRIC TRANSPLANTATION, 2014, 18 (01) : 29 - 34
  • [7] Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis
    Kumar, Juhi
    Shatat, Ibrahim F.
    Skversky, Amy L.
    Woroniecki, Robert P.
    Del Rio, Marcela
    Perelstein, Eduardo M.
    Johnson, Valerie L.
    Mahesh, Shefali
    PEDIATRIC NEPHROLOGY, 2013, 28 (02) : 333 - 338
  • [8] The comprehensive incidence and risk factors of fracture in kidney transplant recipients: A meta-analysis
    Jia, Lei
    Chao, Sheng
    Yang, Qizhen
    Chen, Qian
    Yuan, Zhihui
    Chen, Luobei
    Zhang, Tao
    Zhu, Kejing
    Niu, Yulin
    NEPHROLOGY, 2024, 29 (09) : 588 - 599
  • [9] Incidence of kidney stones in kidney transplant recipients:A systematic review and meta-analysis
    Wisit Cheungpasitporn
    Charat Thongprayoon
    Michael A Mao
    Wonngarm Kittanamongkolchai
    Insara J Jaffer Sathick
    Tsering Dhondup
    Stephen B Erickson
    World Journal of Transplantation, 2016, (04) : 790 - 797
  • [10] Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis
    Hansrivijit, Panupong
    Ghahramani, Nasrollah
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (07) : 1377 - 1387